Pfizer seeks approval for emergency use of corona vaccine in India

New delhi date. Sunday, December 6, 2020

The American company Pfizer has applied to the Drug Controller of India for emergency use of its corona vaccine in India.

Pfizer has become the first company in India to seek permission to use the corona vaccine. Pfizer has recently been granted permission by the British government to use the vaccine in emergencies. Awaiting approval for use.

Approval for emergency use of the vaccine is given by analyzing the effect of the vaccine and its safety beforehand. The results of clinical trials are taken into account for this. Many countries have had to reconsider these norms.

However, the Pfizer vaccine has not been tested in India. The company claims that the vaccine is 95% effective. It has to be stored at room temperature. Countries like India do not have this type of storage facility. It costs 40 40 in the US and may cost more in India.